Ledger.Open graph →
SEC Form D · filed November 4, 2022

Paragon Biosciences Emalex Capital, Inc

Offering
$250.0M
Sold
$185.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NORTHBROOK, IL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Darien J. Parhad · Chicago, ILExecJeffrey J. Aronin · Chicago, ILExec · DirectorAntonio J. Gracias · Chicago, ILDirectorPatrick J. Morris · Chicago, ILExec · DirectorWilliam D. Rahm · New York, NYExec · DirectorPatrick N. Nolan · Atlanta, GAExec · DirectorRicardo Lombardi · New York, NYDirectorAmit Assaraf · New York, NYExecKevin Chavers · New York, NYDirectorAl C. Laskaj · NEW YORK, NYExec · DirectorDana C. Devivo · NEW YORK, NYExecFrancis C. Poli · NEW YORK, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗